Furthermore, we found that the intracellular levels of TAGLN2 were significantly lower in CD8+ T cells isolated from the ascites of HGSOC patients than in peripheral CD8+ T cells from cancer-free women (Fig. 3a). This evidence concerns the gene TAGLN2 and cancer.